Advocacy intelligence hub — real-time data for patient organizations
Tern Therapeutics, LLC — PHASE1, PHASE2
David L Rogers, MD — PHASE1, PHASE2
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Open now
Patient Assistance Programs1
Brineura
BioMarin Pharmaceutical Inc.
Brineura
(CERLIPONASE ALFA)Orphan drugstandardBioMarin Pharmaceutical Inc.
Ronald G Crystal, MD, MD
Weill Medical College of Cornell University
📍 NEW YORK, NY
Ronald G. Crystal, MD, MD
Weill Medical College of Cornell University
📍 NEW YORK, NY
David Jacoby
BioMarin Pharmaceutical
Jonathan W Mink, MD PhD, MD, PhD
University of Rochester
📍 ROCHESTER, NY
David Rogers, MD
Nationwide Children's Hospital
Angela Schulz, MD, PhD
Head of NCL-Specialty Clinic
📍 Hamburg